Agne Zice: Global ITP Awareness Week – A Personal Note!
Agne Zice, Senior Contract Manager at Low Carbon Contracts Company, shared on LinkedIn:
‘‘Global ITP Awareness Week – A Personal Note
This week (22–28 September) marks Global ITP Awareness Week, and I wanted to take a moment to share something personal.
In April 2021, I was diagnosed with Immune Thrombocytopenia (ITP) – a rare autoimmune condition where the body attacks its own platelets, the cells that help your blood clot. It is unpredictable, invisible to most, and often misunderstood.
I have experienced many ups and downs, including hospital visits, relapses, and moments of deep uncertainty.
Over time, I have learned how to live with it, and this year, I have taken a step further by becoming a trustee of the ITP Support Association.
Most people with ITP appear “fine” on the outside – and that is part of the challenge.
Raising awareness helps improve understanding, research, and support for those affected.
If you would like to learn more, please feel free to reach out to me directly, or visit the ITP Support Association website.
If you are wondering how you can help, there are many ways: donating blood or plasma, supporting and participating in fundraising events, donating via the ITP Support Association website, or simply sharing what you have learned.
Thank you for taking the time to read this.”

Stay informed with Hemostasis Today.
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV